Skip to the content 
Source: resistthemainstream.org/new-study-on-ivermectin-should-convince-any-naysayer-dr-pierre-kory/
According to Dr. Pierre Kory, a new study proves that ivermectin effectively prevents the transmission of COVID-19.
During a six-month study in 2020, residents of the Brazilian city of Itajai were given ivermectin upon request. Scientists found that the 100,000 participants in the study were 44 percent less likely to contract COVID-19.
Cureus published the peer-reviewed study on Jan. 15.
Dr. Pierre Kory, president of the Front Line COVID-19 Critical Care Alliance (FLCCC) told the Epoch Times the results of the study "should convince any naysayer," adding, "what they found was astounding."
The study, conducted between July 7 and Dec. 2, 2020, also showed that users of ivermectin enjoyed a statistically significant decrease in hospitalization and mortality.
The FDA and CDC have resisted authorizing the use of ivermectin. Some say their continued refusal to make the drug available is inexplicable, particularly after medical officials noted positive treatment results in India and Japan.
Pressure to allow ivermectin as a preventative or treatment medication for COVID in the United States is mounting. Prominent voices, such as Dr. Robert Malone, the inventor of the nine original mRNA vaccine patents, and podcaster Joe Rogan have encouraged political and medical officials to advocate its use.
Dr. Kory is astounded by the lack of reporting on the peer-reviewed study.
"You would think this would lead major headlines everywhere. And yet, nothing. And this is not new, this censorship of this highly effective science and evidence around repurposed drugs. The censoring of it, it's not new, it's just getting more and more absurd. And it has to stop," he said.
Dr. Gideon Meyerowitz-Katz, an Australian epidemiologist, is not convinced. The Epoch Times reports he referred to Dr. Kory's study as "a fairly simple example of observational research that you'd do on routine medical data" and suggested the controls for the study (designed to mitigate error) were "pretty inadequate given the purpose."
The Food and Drug Administration has approved ivermectin for certain uses, but not for use against COVID-19.
Many have complained that hospitals will not administer ivermectin. Others are concerned that pharmacies will not fill a prescription for ivermectin, even if prescribed by an in-network physician.
